Fish oil pill flunks atrial fibrillation study

Omega-3 fatty acids have become a popular supplement taken by millions of people anxious to avoid heart disease. But the FDA says that a prescription strength version of the fish oil supplement failed to help patients with atrial fibrillation in a large study. A total of 663 patients suffering from erratic heart beats were split into two groups and given either the prescription treatment Lovaza or a placebo over a six month period. The drug was well tolerated but failed to register on the efficacy side of the equation. Report

Suggested Articles

CureVac will spend the bulk of the proceeds on its COVID-19 vaccine, with the rest going to manufacturing, platform development and other programs.

WuXi names Dong to helm new vaccines CDMO; Paragon appoints Jimenez as capital makers lead; Levy joins Spark as CMO.

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.